Medical Subject Headings

Last uploaded: March 22, 2026
Id http://purl.bioontology.org/ontology/MESH/D000076962
http://purl.bioontology.org/ontology/MESH/D000076962
Preferred Name

Receptors, Chimeric Antigen
Definitions
Synthetic cellular receptors that reprogram T-LYMPHOCYTES to selectively bind antigens.
Synonyms
Chimeric T-Cell Receptors
T-Cell Receptor, Chimeric
Chimeric Immunoreceptors
Antigen Receptor, Chimeric
Chimeric Antigen Receptor
Receptor, Chimeric Antigen
Receptors, Artificial T-Cell
Artificial T-Cell Receptors
Chimeric T Cell Receptor
Antigen Receptors, Chimeric
Chimeric T-Cell Receptor
T-Cell Receptors, Chimeric
Immunoreceptors, Chimeric
Artificial T Cell Receptors
Chimeric Antigen Receptors
T-Cell Receptors, Artificial
Chimeric T Cell Receptors
Receptors, Chimeric T-Cell
Receptor, Chimeric T-Cell
See more
See less
Type http://www.w3.org/2002/07/owl#Class

All Properties

definition

Synthetic cellular receptors that reprogram T-LYMPHOCYTES to selectively bind antigens.
altLabel
Chimeric T-Cell Receptors
T-Cell Receptor, Chimeric
Chimeric Immunoreceptors
Antigen Receptor, Chimeric
Chimeric Antigen Receptor
Receptor, Chimeric Antigen
Receptors, Artificial T-Cell
Artificial T-Cell Receptors
Chimeric T Cell Receptor
Antigen Receptors, Chimeric
Chimeric T-Cell Receptor
T-Cell Receptors, Chimeric
Immunoreceptors, Chimeric
Artificial T Cell Receptors
Chimeric Antigen Receptors
T-Cell Receptors, Artificial
Chimeric T Cell Receptors
Receptors, Chimeric T-Cell
Receptor, Chimeric T-Cell
See more
See less
prefLabel
Receptors, Chimeric Antigen
Machine permutation
2019
HN
2019
Mapped from
type
tui
T116
T129
T192
TERMUI
T000935785
T000935787
T000935784
T000996807
T000938919
T000935786
T000996102
See more
See less
TH
NLM (2019)
NLM (2021)
MMR
20210305
notation
D000076962
Inverse of RO
Semantic type UMLS property
Inverse of AQ
http://purl.bioontology.org/ontology/MESH/Q000097
http://purl.bioontology.org/ontology/MESH/Q000627
http://purl.bioontology.org/ontology/MESH/Q000648
http://purl.bioontology.org/ontology/MESH/Q000276
http://purl.bioontology.org/ontology/MESH/Q000138
http://purl.bioontology.org/ontology/MESH/Q000266
http://purl.bioontology.org/ontology/MESH/Q000378
http://purl.bioontology.org/ontology/MESH/Q000008
http://purl.bioontology.org/ontology/MESH/Q000032
http://purl.bioontology.org/ontology/MESH/Q000037
http://purl.bioontology.org/ontology/MESH/Q000302
http://purl.bioontology.org/ontology/MESH/Q000145
http://purl.bioontology.org/ontology/MESH/Q000737
http://purl.bioontology.org/ontology/MESH/Q000819
http://purl.bioontology.org/ontology/MESH/Q000187
http://purl.bioontology.org/ontology/MESH/Q000235
http://purl.bioontology.org/ontology/MESH/Q000528
See more
See less
FX
D016219
DX
20190101
cui
C4039583
DC
1
MN
D12.776.543.750.655.500
D12.776.543.750.705.816.824.150
D12.776.826.387.500
AN
for CAR-T Cell Therapy, coordinate with CHIMERIC ANTIGEN RECEPTOR THERAPY see IMMUNOTHERAPY, ADOPTIVE
AQL
AD AG AI AN BL CH CL CS DE GE HI IM IP ME RE TU UL
Inverse of RB
0
MDA
20180110
subClassOf
Add comment
Add proposal
Delete Subject Author Type Created
No notes to display